Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

223.53 -3.13 (-1.38%)

Streaming Delayed Price Updated: 2:43 PM EDT, Apr 28, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,609,640
Open	227.25
Bid (Size)	223.40 (200)
Ask (Size)	223.84 (200)
Prev. Close	226.66
Today's Range	221.00 - 228.15
52wk Range	150.89 - 250.74
Shares Outstanding	57,152,295
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

In a move that signals a transformative shift from a clinical-stage biotech to a commercial-market leader, Ascendis Pharma (NASDAQ: ASND) officially launched its third major product, YUVIWEL...

Via MarketMinute

Agriculture Stock Up 53% Draws $12 Million Bet. Here's What Long-Term Investors Should Know ↗

March 20, 2026

This agribusiness firm delivers grain, renewables, and plant nutrient solutions to commercial and industrial clients worldwide.

Via The Motley Fool

Performance

YTD	+4.8%	+4.8%
1 Month	+2.4%	+2.4%
3 Month	-4.3%	-4.3%
6 Month	+10.0%	+10.0%
1 Year	+35.6%	+35.6%

More News

Ascendis (ASND) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Shares Drop After Q4 Earnings Miss on Wider-Than-Expected Loss ↗

February 11, 2026

Via Chartmill

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗

February 22, 2026

Via The Motley Fool

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗

February 22, 2026

Via The Motley Fool

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction ↗

February 22, 2026

Via The Motley Fool

ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Minervini Trend Template with High Growth Momentum ↗

January 28, 2026

Via Chartmill

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

A Look Ahead: Ascendis Pharma's Earnings Forecast ↗

November 11, 2025

Via Benzinga

$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗

February 22, 2026

Via The Motley Fool

Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗

February 11, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Passes Minervini's Trend Template and High Growth Momentum Scan ↗

December 25, 2025

Via Chartmill

Why Dyne Therapeutics Stock Was Crushing it This Week ↗

November 21, 2025

Via The Motley Fool

European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility

November 19, 2025

Via MarketMinute

Ascendis (ASND) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

Ascendis Pharma Likely To Report Narrower Q3 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

November 12, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years ↗

October 29, 2025

Via Benzinga

Looking Into Ascendis Pharma AS's Recent Short Interest ↗

October 21, 2025

Via Benzinga

Ascendis Pharma A/S - ADR (NASDAQ:ASND) Shows Strong Growth Momentum in Technical and Fundamental Analysis ↗

October 14, 2025

Via Chartmill

What Does the Market Think About Ascendis Pharma AS? ↗

September 29, 2025

Via Benzinga

$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today ↗

September 25, 2025

Via Benzinga

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment ↗

September 08, 2025

Via Benzinga

$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today ↗

September 08, 2025

Via Benzinga

Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today ↗

September 04, 2025

Via Benzinga

Frequently Asked Questions

Is Ascendis Pharma A/S - Ordinary Share publicly traded?

Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.

What exchange does Ascendis Pharma A/S - Ordinary Share trade on?

Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?

The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market

What is the current price of Ascendis Pharma A/S - Ordinary Share?

The current price of Ascendis Pharma A/S - Ordinary Share is 223.53

When was Ascendis Pharma A/S - Ordinary Share last traded?

The last trade of Ascendis Pharma A/S - Ordinary Share was at 04/28/26 02:43 PM ET

What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?

The market capitalization of Ascendis Pharma A/S - Ordinary Share is 12.77B

How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?

Ascendis Pharma A/S - Ordinary Share has 13B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.